Leorah Freeman, M.D., Ph.D.

Dell Medical School, The University of Texas at Austin

Project Overview

Neurologist Léorah Freeman is the director of the Multiple Sclerosis Imaging and Outcomes Research Laboratory at The University of Texas at Austin’s Dell Medical School. As a physician-scientist, Dr. Freeman received training in both patient care and scientific research. She earned her M.D. and Ph.D.
from Université Pierre et Marie Curie in Paris, France. She specializes in the care of people with MS and other neuroinflammatory conditions.

Background

The Kathleen C. Moore Research Fund for Hope was established at Dell Medical School in September 2022. The fund will support research and programming related to multiple sclerosis under the direction of Dr. Freeman, a physician-scientist on the front lines of improving care for people and families affected by MS.

The Study

Dr. Freeman’s innovative research spans initiatives to provide more equitable MS care, support healthy aging with MS, bring new technology and state-of-the-art MRI analysis to the bedside, and advance precision medicine in MS. Funds will accelerate and expand Dr. Freeman’s work to better care for people living with MS and enable her to gather preliminary data needed to qualify for large-scale federal funding.

What’s Next

Dr. Freeman and her team are currently recruiting a diverse cohort of patients to study the impact of demographic, social and disease-specific factors on MS outcomes among people from vulnerable communities. She is also identifying predictive biomarkers of disease progression and response to therapies in MS patients over age 50 to establish best practices for the management of MS in older adults. Finally, she is working with UT engineers to develop a process to make MRI imaging — the gold standard in imaging for MS — more valuable, comfortable, and useful for patients and clinicians.

Project Overview

Neurologist Léorah Freeman is the director of the Multiple Sclerosis Imaging and Outcomes Research Laboratory at The University of Texas at Austin’s Dell Medical School. As a physician-scientist, Dr. Freeman received training in both patient care and scientific research. She earned her M.D. and Ph.D.
from Université Pierre et Marie Curie in Paris, France. She specializes in the care of people with MS and other neuroinflammatory conditions.

Background

The Kathleen C. Moore Research Fund for Hope was established at Dell Medical School in September 2022. The fund will support research and programming related to multiple sclerosis under the direction of Dr. Freeman, a physician-scientist on the front lines of improving care for people and families affected by MS.

The Study

Dr. Freeman’s innovative research spans initiatives to provide more equitable MS care, support healthy aging with MS, bring new technology and state-of-the-art MRI analysis to the bedside, and advance precision medicine in MS. Funds will accelerate and expand Dr. Freeman’s work to better care for people living with MS and enable her to gather preliminary data needed to qualify for large-scale federal funding.

What’s Next

Dr. Freeman and her team are currently recruiting a diverse cohort of patients to study the impact of demographic, social and disease-specific factors on MS outcomes among people from vulnerable communities. She is also identifying predictive biomarkers of disease progression and response to therapies in MS patients over age 50 to establish best practices for the management of MS in older adults. Finally, she is working with UT engineers to develop a process to make MRI imaging — the gold standard in imaging for MS — more valuable, comfortable, and useful for patients and clinicians.